Last reviewed · How we verify
Plasminogen Activator — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Plasminogen Activator (Plasminogen Activator) — Grifols Therapeutics LLC.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Plasminogen Activator TARGET | Plasminogen Activator | Grifols Therapeutics LLC | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Plasminogen Activator CI watch — RSS
- Plasminogen Activator CI watch — Atom
- Plasminogen Activator CI watch — JSON
- Plasminogen Activator alone — RSS
Cite this brief
Drug Landscape (2026). Plasminogen Activator — Competitive Intelligence Brief. https://druglandscape.com/ci/plasminogen-activator. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab